[{"Assets_0_Q2_USD":155149000.0,"CommonStockSharesOutstanding_0_Q2_shares":24195000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19327000.0,"NetIncomeLoss_1_Q2_USD":-12427000.0,"NetIncomeLoss_2_Q2_USD":-21443000.0,"StockholdersEquity_0_Q2_USD":142101000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190813"}]